Back

B3 agonists.

27 May 2019 (17:34 - 17:47)
Organised by:
Congress Presentation Part of: Emerging therapies in heart failure Pathophysiology HFA Premium Access Heart Failure 2019

6 More presentations in this session

Presentation thumbnail
Drugs targeting cardiac metabolism.
Professor G. Rosano (London, GB)
Slides Video
Presentation thumbnail
Apelin pathway.
Professor P. Ponikowski (Wroclaw, PL)
Slides Video
Presentation thumbnail
Omecaptiv.
Professor J. Cleland (Glasgow, GB)
Slides Video
Presentation thumbnail
Vericiguat.
Professor B. Pieske (Rostock, DE)
Video
Presentation thumbnail
Nitroxyl donors.
Professor V. Mitrovic (Nauheim, DE)
Slides Video

Access the full session

Session thumbnail
Emerging therapies in heart failure

The Event

Event poster

Heart Failure 2019

27 May 2019 17:34 CET
You may be interested in
thumbnail
Congress Session
Beta3 adrenergic agonists in the clinic: the end of the beginning
28 August 2022
thumbnail
Congress Presentation
Persistence of autoantibodies directed against the beta-1-adrenoceptor in patients with heart failure after treatment with BC 007 (Rovunaptabin). Results of a phase IIa study.
12 May 2024
thumbnail
Congress Presentation
Asthma and the risk of cardiac events among patients with long QT Syndrome after age 40
27 August 2023
thumbnail
Congress Presentation
Pregnancy and arrhythmia management in patients with inherited cardiomyopathies and channelopathies
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources